• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多中心整合分析 TRP 通道揭示了免疫抑制微环境激活的潜在机制,并确定了一种基于机器学习的特征,可改善神经胶质瘤的预后。

Multicenter integration analysis of TRP channels revealed potential mechanisms of immunosuppressive microenvironment activation and identified a machine learning-derived signature for improving outcomes in gliomas.

机构信息

Department of Neurosurgery, Renmin Hospital of Wuhan University, Wuhan, China.

Central Laboratory, Renmin Hospital of Wuhan University, Wuhan, China.

出版信息

CNS Neurosci Ther. 2024 Jul;30(7):e14816. doi: 10.1111/cns.14816.

DOI:10.1111/cns.14816
PMID:38948951
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11215471/
Abstract

AIM

This study aimed to explore the mechanisms of transient receptor potential (TRP) channels on the immune microenvironment and develop a TRP-related signature for predicting prognosis, immunotherapy response, and drug sensitivity in gliomas.

METHODS

Based on the unsupervised clustering algorithm, we identified novel TRP channel clusters and investigated their biological function, immune microenvironment, and genomic heterogeneity. In vitro and in vivo experiments revealed the association between TRPV2 and macrophages. Subsequently, based on 96 machine learning algorithms and six independent glioma cohorts, we constructed a machine learning-based TRP channel signature (MLTS). The performance of the MLTS in predicting prognosis, immunotherapy response, and drug sensitivity was evaluated.

RESULTS

Patients with high expression levels of TRP channel genes had worse prognoses, higher tumor mutation burden, and more activated immunosuppressive microenvironment. Meanwhile, TRPV2 was identified as the most essential regulator in TRP channels. TRPV2 activation could promote macrophages migration toward malignant cells and alleviate glioma prognosis. Furthermore, MLTS could work independently of common clinical features and present stable and superior prediction performance.

CONCLUSION

This study investigated the comprehensive effect of TRP channel genes in gliomas and provided a promising tool for designing effective, precise treatment strategies.

摘要

目的

本研究旨在探讨瞬时受体电位(TRP)通道在免疫微环境中的作用机制,并建立一个与 TRP 相关的标志物,用于预测胶质瘤的预后、免疫治疗反应和药物敏感性。

方法

我们基于无监督聚类算法,确定了新的 TRP 通道簇,并研究了它们的生物学功能、免疫微环境和基因组异质性。体外和体内实验揭示了 TRPV2 与巨噬细胞之间的关联。随后,我们基于 96 种机器学习算法和 6 个独立的胶质瘤队列,构建了基于机器学习的 TRP 通道标志物(MLTS)。评估了 MLTS 在预测预后、免疫治疗反应和药物敏感性方面的性能。

结果

高表达 TRP 通道基因的患者预后较差,肿瘤突变负担较高,免疫抑制微环境更为活跃。同时,TRPV2 被鉴定为 TRP 通道中最关键的调节因子。TRPV2 的激活可以促进巨噬细胞向恶性细胞迁移,并改善胶质瘤的预后。此外,MLTS 可以独立于常见的临床特征,具有稳定和优越的预测性能。

结论

本研究全面探讨了 TRP 通道基因在胶质瘤中的综合作用,并为设计有效、精确的治疗策略提供了有前途的工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bc3/11215471/e55b8e6431c8/CNS-30-e14816-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bc3/11215471/a4876c03846c/CNS-30-e14816-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bc3/11215471/5a51655e5f4a/CNS-30-e14816-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bc3/11215471/a3d7ef1e4967/CNS-30-e14816-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bc3/11215471/ed9384d6aba9/CNS-30-e14816-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bc3/11215471/4b285f04c91a/CNS-30-e14816-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bc3/11215471/3fe4b241e189/CNS-30-e14816-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bc3/11215471/5c89bde97e3a/CNS-30-e14816-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bc3/11215471/e55b8e6431c8/CNS-30-e14816-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bc3/11215471/a4876c03846c/CNS-30-e14816-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bc3/11215471/5a51655e5f4a/CNS-30-e14816-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bc3/11215471/a3d7ef1e4967/CNS-30-e14816-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bc3/11215471/ed9384d6aba9/CNS-30-e14816-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bc3/11215471/4b285f04c91a/CNS-30-e14816-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bc3/11215471/3fe4b241e189/CNS-30-e14816-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bc3/11215471/5c89bde97e3a/CNS-30-e14816-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bc3/11215471/e55b8e6431c8/CNS-30-e14816-g005.jpg

相似文献

1
Multicenter integration analysis of TRP channels revealed potential mechanisms of immunosuppressive microenvironment activation and identified a machine learning-derived signature for improving outcomes in gliomas.多中心整合分析 TRP 通道揭示了免疫抑制微环境激活的潜在机制,并确定了一种基于机器学习的特征,可改善神经胶质瘤的预后。
CNS Neurosci Ther. 2024 Jul;30(7):e14816. doi: 10.1111/cns.14816.
2
Integration analysis of cell division cycle-associated family genes revealed potential mechanisms of gliomagenesis and constructed an artificial intelligence-driven prognostic signature.细胞分裂周期相关家族基因的整合分析揭示了胶质瘤发生的潜在机制,并构建了一个人工智能驱动的预后特征。
Cell Signal. 2024 Jul;119:111168. doi: 10.1016/j.cellsig.2024.111168. Epub 2024 Apr 9.
3
Grade scoring system reveals distinct molecular subtypes and identifies KIF20A as a novel biomarker for predicting temozolomide treatment efficiency in gliomas.分级评分系统揭示了不同的分子亚型,并将KIF20A鉴定为预测胶质瘤替莫唑胺治疗疗效的新型生物标志物。
J Cancer Res Clin Oncol. 2023 Sep;149(12):9857-9876. doi: 10.1007/s00432-023-04898-6. Epub 2023 May 29.
4
Development and validation of cuproptosis molecular subtype-related signature for predicting immune prognostic characterization in gliomas.铜死亡分子亚型相关特征的建立和验证,用于预测脑胶质瘤的免疫预后特征。
J Cancer Res Clin Oncol. 2023 Oct;149(13):11499-11515. doi: 10.1007/s00432-023-05021-5. Epub 2023 Jul 1.
5
Diagnostic test accuracy and cost-effectiveness of tests for codeletion of chromosomal arms 1p and 19q in people with glioma.染色体臂 1p 和 19q 缺失的检测在胶质瘤患者中的诊断准确性和成本效益。
Cochrane Database Syst Rev. 2022 Mar 2;3(3):CD013387. doi: 10.1002/14651858.CD013387.pub2.
6
Comprehensive analysis of single-cell and bulk RNA sequencing data reveals an EGFR signature for predicting immunotherapy response and prognosis in pan-cancer.单细胞和批量RNA测序数据的综合分析揭示了一种用于预测泛癌免疫治疗反应和预后的EGFR特征。
Front Immunol. 2025 Jun 12;16:1604394. doi: 10.3389/fimmu.2025.1604394. eCollection 2025.
7
Molecular subtypes of lung adenocarcinoma patients for prognosis and therapeutic response prediction with machine learning on 13 programmed cell death patterns.基于 13 种程序性细胞死亡模式的机器学习对肺腺癌患者预后和治疗反应预测的分子亚型。
J Cancer Res Clin Oncol. 2023 Oct;149(13):11351-11368. doi: 10.1007/s00432-023-05000-w. Epub 2023 Jun 28.
8
Bayesian Optimization-Enhanced Machine Learning for Osteosarcoma Risk Stratification Based on Sphingolipid Metabolism.基于鞘脂代谢的贝叶斯优化增强型机器学习用于骨肉瘤风险分层
Hum Mutat. 2025 Jul 11;2025:2904964. doi: 10.1155/humu/2904964. eCollection 2025.
9
Computed tomography-based radiomics predicts prognostic and treatment-related levels of immune infiltration in the immune microenvironment of clear cell renal cell carcinoma.基于计算机断层扫描的放射组学可预测透明细胞肾细胞癌免疫微环境中免疫浸润的预后及治疗相关水平。
BMC Med Imaging. 2025 Jul 1;25(1):213. doi: 10.1186/s12880-025-01749-3.
10
From pixels to prognosis: leveraging radiomics and machine learning to predict IDH1 genotype in gliomas.从像素到预后:利用影像组学和机器学习预测胶质瘤中的异柠檬酸脱氢酶1(IDH1)基因型
Neurosurg Rev. 2025 Apr 29;48(1):396. doi: 10.1007/s10143-025-03515-z.

引用本文的文献

1
Current status, hotspots and frontiers of ion channel-related research in glioblastoma: a bibliometric analysis from 2005 to 2024.胶质母细胞瘤中离子通道相关研究的现状、热点及前沿:2005年至2024年的文献计量分析
Front Oncol. 2025 Jun 4;15:1588598. doi: 10.3389/fonc.2025.1588598. eCollection 2025.

本文引用的文献

1
Cuproptosis facilitates immune activation but promotes immune escape, and a machine learning-based cuproptosis-related signature is identified for predicting prognosis and immunotherapy response of gliomas.铜死亡促进免疫激活但促进免疫逃逸,基于机器学习的铜死亡相关特征可用于预测脑胶质瘤的预后和免疫治疗反应。
CNS Neurosci Ther. 2024 Feb;30(2):e14380. doi: 10.1111/cns.14380. Epub 2023 Jul 28.
2
TRP (transient receptor potential) ion channel family: structures, biological functions and therapeutic interventions for diseases.瞬时受体电位 (transient receptor potential) 离子通道家族:结构、生物学功能及疾病的治疗干预。
Signal Transduct Target Ther. 2023 Jul 5;8(1):261. doi: 10.1038/s41392-023-01464-x.
3
Glioma diagnosis and therapy: Current challenges and nanomaterial-based solutions.
神经胶质瘤的诊断和治疗:当前的挑战与基于纳米材料的解决方案。
J Control Release. 2022 Dec;352:338-370. doi: 10.1016/j.jconrel.2022.09.065. Epub 2022 Oct 27.
4
The 2021 WHO Classification of Tumors of the Central Nervous System: An update on pediatric low-grade gliomas and glioneuronal tumors.2021 年世卫组织中枢神经系统肿瘤分类:儿童低级别胶质瘤和神经胶质神经元肿瘤的更新。
Brain Pathol. 2022 Jul;32(4):e13060. doi: 10.1111/bpa.13060. Epub 2022 Feb 25.
5
Glioma targeted therapy: insight into future of molecular approaches.脑胶质瘤靶向治疗:分子靶向治疗的未来展望。
Mol Cancer. 2022 Feb 8;21(1):39. doi: 10.1186/s12943-022-01513-z.
6
Epithelial to Mesenchymal Transition: Key Regulator of Pancreatic Ductal Adenocarcinoma Progression and Chemoresistance.上皮-间质转化:胰腺导管腺癌进展和化疗耐药的关键调节因子
Cancers (Basel). 2021 Nov 4;13(21):5532. doi: 10.3390/cancers13215532.
7
Advances in TRP channel drug discovery: from target validation to clinical studies.TRP 通道药物发现的进展:从靶点确证到临床研究。
Nat Rev Drug Discov. 2022 Jan;21(1):41-59. doi: 10.1038/s41573-021-00268-4. Epub 2021 Sep 15.
8
Transient Receptor Potential (TRP) Ion Channels Involved in Malignant Glioma Cell Death and Therapeutic Perspectives.参与恶性胶质瘤细胞死亡的瞬时受体电位(TRP)离子通道及治疗前景
Front Cell Dev Biol. 2021 Aug 12;9:618961. doi: 10.3389/fcell.2021.618961. eCollection 2021.
9
TRP Channels in Brain Tumors.脑肿瘤中的瞬时受体电位通道
Front Cell Dev Biol. 2021 Apr 13;9:617801. doi: 10.3389/fcell.2021.617801. eCollection 2021.
10
Tumor Immune Microenvironment during Epithelial-Mesenchymal Transition.上皮-间质转化过程中的肿瘤免疫微环境。
Clin Cancer Res. 2021 Sep 1;27(17):4669-4679. doi: 10.1158/1078-0432.CCR-20-4459. Epub 2021 Apr 7.